Report Detail
Global (United States, European Union and China) Next-Generation Drug-Eluting Stent Market Research Report 2019-2025
- RnM3650399 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Other
Next-generation drug-eluting stent is advantageous as it offers improved deliverability by using materials like cobalt chromium, cobalt nickel, and cobalt alloy, this results in significant reduction in strut width, and enhance stent flexibility. In next-generation drug eluting stent, several drugs are coated in stents to address multiple restenosis pathways by altering drug release kinetics that mimics restenosis cascade. In addition, next-generation drug-eluting stent utilizes bioabsorbable polymers to reduce complications of late stent thrombosis, and bioresorbable drug-eluting scaffold plays a vital role in transforming coronary artery disease treatment.
The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease. In addition, presence sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of next-generation drug eluting stent market. The market in Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities. However, market in the Middle East & Africa shows the steady growth during the forecast period.
In 2019, the market size of Next-Generation Drug-Eluting Stent is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Next-Generation Drug-Eluting Stent.
This report studies the global market size of Next-Generation Drug-Eluting Stent, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Next-Generation Drug-Eluting Stent production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbott
Biosensors International
Medtronic
Sorin Group
SMT
Terumo
...
Market Segment by Product Type
Cobalt Chromium
Stainless Steel
Others
Market Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Next-Generation Drug-Eluting Stent status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Next-Generation Drug-Eluting Stent manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Next-Generation Drug-Eluting Stent are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Cobalt Chromium
- 1.3.3 Stainless Steel
- 1.3.4 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Next-Generation Drug-Eluting Stent Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.4.4 Ambulatory Surgical Centers
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Next-Generation Drug-Eluting Stent Production Value 2014-2025
- 2.1.2 Global Next-Generation Drug-Eluting Stent Production 2014-2025
- 2.1.3 Global Next-Generation Drug-Eluting Stent Capacity 2014-2025
- 2.1.4 Global Next-Generation Drug-Eluting Stent Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Next-Generation Drug-Eluting Stent Market Size CAGR of Key Regions
- 2.2.2 Global Next-Generation Drug-Eluting Stent Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Next-Generation Drug-Eluting Stent Capacity by Manufacturers
- 3.1.2 Global Next-Generation Drug-Eluting Stent Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Next-Generation Drug-Eluting Stent Revenue by Manufacturers (2014-2019)
- 3.2.2 Next-Generation Drug-Eluting Stent Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Next-Generation Drug-Eluting Stent Market Concentration Ratio (CR5 and HHI)
- 3.3 Next-Generation Drug-Eluting Stent Price by Manufacturers
- 3.4 Key Manufacturers Next-Generation Drug-Eluting Stent Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Next-Generation Drug-Eluting Stent Market
- 3.6 Key Manufacturers Next-Generation Drug-Eluting Stent Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Cobalt Chromium Production and Production Value (2014-2019)
- 4.1.2 Stainless Steel Production and Production Value (2014-2019)
- 4.1.3 Others Production and Production Value (2014-2019)
- 4.2 Global Next-Generation Drug-Eluting Stent Production Market Share by Type
- 4.3 Global Next-Generation Drug-Eluting Stent Production Value Market Share by Type
- 4.4 Next-Generation Drug-Eluting Stent Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Next-Generation Drug-Eluting Stent Consumption by Application
6 Production by Regions
- 6.1 Global Next-Generation Drug-Eluting Stent Production (History Data) by Regions 2014-2019
- 6.2 Global Next-Generation Drug-Eluting Stent Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Next-Generation Drug-Eluting Stent Production Growth Rate 2014-2019
- 6.3.2 United States Next-Generation Drug-Eluting Stent Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Next-Generation Drug-Eluting Stent Import & Export
- 6.4 European Union
- 6.4.1 European Union Next-Generation Drug-Eluting Stent Production Growth Rate 2014-2019
- 6.4.2 European Union Next-Generation Drug-Eluting Stent Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Next-Generation Drug-Eluting Stent Import & Export
- 6.5 China
- 6.5.1 China Next-Generation Drug-Eluting Stent Production Growth Rate 2014-2019
- 6.5.2 China Next-Generation Drug-Eluting Stent Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Next-Generation Drug-Eluting Stent Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Next-Generation Drug-Eluting Stent Consumption by Regions
- 7.1 Global Next-Generation Drug-Eluting Stent Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Next-Generation Drug-Eluting Stent Consumption by Type
- 7.2.2 United States Next-Generation Drug-Eluting Stent Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Next-Generation Drug-Eluting Stent Consumption by Type
- 7.3.2 European Union Next-Generation Drug-Eluting Stent Consumption by Application
- 7.4 China
- 7.4.1 China Next-Generation Drug-Eluting Stent Consumption by Type
- 7.4.2 China Next-Generation Drug-Eluting Stent Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Next-Generation Drug-Eluting Stent Consumption by Type
- 7.5.2 Rest of World Next-Generation Drug-Eluting Stent Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Abbott
- 8.1.1 Abbott Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Next-Generation Drug-Eluting Stent
- 8.1.4 Next-Generation Drug-Eluting Stent Product Introduction
- 8.1.5 Abbott Recent Development
- 8.2 Biosensors International
- 8.2.1 Biosensors International Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Next-Generation Drug-Eluting Stent
- 8.2.4 Next-Generation Drug-Eluting Stent Product Introduction
- 8.2.5 Biosensors International Recent Development
- 8.3 Medtronic
- 8.3.1 Medtronic Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Next-Generation Drug-Eluting Stent
- 8.3.4 Next-Generation Drug-Eluting Stent Product Introduction
- 8.3.5 Medtronic Recent Development
- 8.4 Sorin Group
- 8.4.1 Sorin Group Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Next-Generation Drug-Eluting Stent
- 8.4.4 Next-Generation Drug-Eluting Stent Product Introduction
- 8.4.5 Sorin Group Recent Development
- 8.5 SMT
- 8.5.1 SMT Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Next-Generation Drug-Eluting Stent
- 8.5.4 Next-Generation Drug-Eluting Stent Product Introduction
- 8.5.5 SMT Recent Development
- 8.6 Terumo
- 8.6.1 Terumo Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Next-Generation Drug-Eluting Stent
- 8.6.4 Next-Generation Drug-Eluting Stent Product Introduction
- 8.6.5 Terumo Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Next-Generation Drug-Eluting Stent Capacity, Production Forecast 2019-2025
- 9.1.2 Global Next-Generation Drug-Eluting Stent Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Next-Generation Drug-Eluting Stent Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Next-Generation Drug-Eluting Stent Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Next-Generation Drug-Eluting Stent Production Forecast by Type
- 9.7.2 Global Next-Generation Drug-Eluting Stent Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Next-Generation Drug-Eluting Stent Sales Channels
- 10.2.2 Next-Generation Drug-Eluting Stent Distributors
- 10.3 Next-Generation Drug-Eluting Stent Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Next-Generation Drug-Eluting Stent. Industry analysis & Market Report on Next-Generation Drug-Eluting Stent is a syndicated market report, published as Global (United States, European Union and China) Next-Generation Drug-Eluting Stent Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Next-Generation Drug-Eluting Stent market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
